7152 CAHtalyst: Results from the Randomized, Double-Blind, Placebo-Controlled Period of A Phase 3 Trial of Crinecerfont, A Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, in Adults with Classic Congenital Adrenal Hyperplasia
Journal of the Endocrine Society(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined